Dr. Hamdan Hamdan is an Assistant Professor at Khalifa University, specializing in neurodegenerative diseases and autism spectrum disorders (ASD). His recent ASD genetics research identified many novel genetic variants in children from the UAE, shedding light on key neuronal functions, including axon growth, synapse organization, and membrane trafficking. Using whole exome sequencing, his study aims to develop molecular diagnostic tools and personalized interventions for ASD, a growing concern in the UAE, affecting 1 in 146 births. A leader in gene therapy and neurogenetics, he specializes in CRISPR/Cas9 gene editing, viral vector design, and transgenic model development to advance neurological research. His work continues to push the boundaries of precision medicine, driving innovative solutions for neurological and neurodevelopmental disorders.